- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pompe's Disease
Total 379290 results
-
Duke UniversitySanofiRecruiting
-
Duke UniversityGenzyme, a Sanofi CompanyRecruitingPompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
Valerion Therapeutics, LLCTerminatedPompe DiseaseUnited States, United Kingdom
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI)CompletedPompe DiseaseUnited States
-
BioMarin PharmaceuticalCompletedPompe DiseaseUnited States, United Kingdom, France, Australia, Germany
-
BioMarin PharmaceuticalTerminatedPompe DiseaseUnited States, United Kingdom, Australia, France, Germany, New Zealand
-
University of FloridaCompletedPompe DiseaseUnited States
-
National Taiwan University HospitalUnknown
-
Genzyme, a Sanofi CompanyTerminatedPompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe DiseaseUnited States
-
University of FloridaAmicus TherapeuticsCompletedLysosomal Storage Diseases | Glycogen Storage Disease Type II | Pompe DiseaseUnited States
-
National Taiwan University HospitalRecruiting
-
National Taiwan University HospitalRecruiting
-
Amicus TherapeuticsActive, not recruitingPompe DiseaseUnited States, Netherlands, United Kingdom, Australia, Germany, New Zealand
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Asklepios Biopharmaceutical, Inc.Active, not recruiting
-
University of FloridaLacerta TherapeuticsCompletedPompe DiseaseUnited States
-
University of FloridaBioMarin PharmaceuticalCompleted
-
LMU KlinikumGenzyme, a Sanofi CompanyCompletedPompe DiseaseGermany, Taiwan, Italy
-
Amicus TherapeuticsCompleted
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalUnknown
-
Fundació Institut de Recerca de l'Hospital de la...Genzyme, a Sanofi CompanyUnknown
-
National Taiwan University HospitalCompleted
-
Amicus TherapeuticsCompletedGlycogen Storage Disease Type II | Pompe DiseaseUnited States
-
Serhat Gumrukcu, MD PhDFrida Therapeutics LLCRecruiting
-
Amicus TherapeuticsAvailable
-
Duke UniversityCompleted
-
Duke UniversityGenzyme, a Sanofi CompanyCompleted
-
Duke UniversityCompletedPompe DiseaseUnited States
-
Duke UniversityCompleted
-
Dwight Koeberl, M.D., Ph.D.Completed
-
University of California, IrvineGenzyme, a Sanofi CompanyCompletedPompe DiseaseUnited States
-
Amicus TherapeuticsTerminated
-
University of FloridaTerminated
-
O & O Alpan LLCCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
National Taiwan University HospitalUnknown
-
Children's Healthcare of AtlantaTerminatedCongenital Disorders
-
Duke UniversityCompleted
-
Genzyme, a Sanofi CompanyRecruitingGlycogen Storage Disease Type II | Pompe DiseaseHungary, Croatia, Serbia, United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Denmark, France, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Japan, Jordan, Korea, Republic of, Kuwait and more
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe Disease Infantile-OnsetUnited States, France, South Africa
-
Genzyme, a Sanofi CompanyCompletedPompe DiseaseBelgium, United States, Czechia, Germany, Italy, Taiwan
-
University of FloridaAmicus TherapeuticsTerminatedPompe Disease | Hypersensitivity Reaction
-
Rambam Health Care CampusUnknown
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II) | Acid Maltase DeficiencyUnited States, Belgium, Denmark, France, Germany, Netherlands, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II)United States, Russian Federation, United Kingdom, Bulgaria, India, Ukraine